Login with your work email address to view charts. No credit card required.
| Art Unit: | 1623 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1620 — Biomedicinal Chemistry |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 556 — Organic compounds -- part of the class 532-570 series 536 — Organic compounds -- part of the class 532-570 series 424 — Drug, bio-affecting and body treating compositions 568 — Organic compounds -- part of the class 532-570 series 562 — Organic compounds -- part of the class 532-570 series 560 — Organic compounds -- part of the class 532-570 series 570 — Organic compounds -- part of the class 532-570 series 427 — Coating processes 554 — Organic compounds -- part of the class 532-570 series |
| Phone: | (571) 270-3463 |
| Email: | pancham.bakshi@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Gen Chem |
| Service: | 14 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 71% over 761 cases |
|---|---|
| Difficulty: | Medium |
| Difficulty Percentile: | 60th
|
With Examiner Bakshi, you have a 71% chance of getting an issued patent by 3 years after the first office action. Examiner Bakshi is a medium examiner and in the 60th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Bakshi, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Bakshi's grant rate is higher than that of Art Unit 1623 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Bakshi | 1.4 |
| Art Unit 1623 | 1.5 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.